BELS Members who support the organization at a higher level to help accelerate our progress.
BELS Springboard Contributors
BELS greatly appreciates our most generous members. Springboard Contributors help put BELS on a firmer financial footing and enable delivery of expanded programming to encourage greater collaboration and faster progress, and supporting our work to extend the global reputation, reach and impact of the UK life sciences sector which is so critical to the UK economy.
Clive Meanwell, CEO, Population Health Partners , New York, NY
BELS Sustaining Members
BELS gratefully acknowledges our Sustaining Members who generously support BELS. Their investment in the organisation helps to support the planning and delivery of BELS activities and to extend the UK’s heritage of scientific excellence in the spirit of collaboration, innovation and kinship.
Usman “Oz” Azam, President & CEO, Tmunity, Philadelphia, PA
Mark Bamforth, President & CEO, Arranta Bio, Cambridge, MA
Dan Bradbury, Managing Member, BioBrit; Executive Chair & Co-founder Equillium, La Jolla, CA
David Ebsworth Chair of Supervisory Board, Synlab, Munich, Germany
Andrew Parkinson, Chief Executive Officer, XPD Consulting, Shawnee, Kansas
BELS Charter Members
BELS gratefully acknowledges our Charter Members who champion the BELS cause and help support its operation with an enhanced commitment on an annual basis.
Bruce Carter, Board Director
Tim Clackson, President & CEO, Theseus Pharmaceuticals, Cambridge MA
Sean McCarthy, CEO, CytomX Therapeutics, South San Francisco, CA
BELS Founding Members
BELS gratefully acknowledges our early Founding Members who generously supported BELS financially to help us re-launch BELS globally in 2016. Their contributions have helped extend the UK’s heritage of scientific excellence in the spirit of collaboration, innovation and kinship.
Mark Bamforth, President & CEO, Arranta Bio, Cambridge MA
Dr Dominic P Behan, President & CEO, Sentia Medical Sciences, San Diego CA
Dr Simon Blake, Sr Director, Scientific Licensing, Immunology, Janssen Research & Development, Berwyn PA
Dr Timothy P Clackson, President & EVP R&D – Xilio Therapeutics, Cambridge MA
Nicola Downes, Chief Financial Officer, uLab Systems, Redwood City CA
Dr David R Ebsworth, Chairman, Verona Pharma and Actimed Therapeutics, Switzerland
Dr Christopher H Evans, Professor & Director of Rehabilitation Medicine Research Center, Mayo Clinic, Rochester MN
Dr Clive A Meanwell, Ex Chief Executive Officer, The Medicines Company, Parsippany NJ
Dr Stephen Naylor, Chairman & CEO, MaiHealth, Indianapolis IN